Research Progress in Pharmacological Effects of Ophiopogonin D

SUN Yan, ZHU Li-hong, CHEN Jun-yi, LI Rui-hua, ZHAO Fang-li, ZHOU Jing-yi

PDF(1436 KB)
KANGGANRAN YAOXUE ›› 2024, Vol. 21 ›› Issue (1) : 1-5. DOI: 10.13493/j.issn.1672-7878.2024.01-001

Research Progress in Pharmacological Effects of Ophiopogonin D

  • SUN Yan*1, ZHU Li-hong*2, CHEN Jun-yi, LI Rui-hua, ZHAO Fang-li, ZHOU Jing-yi
Author information +
History +

Abstract

Ophiopogonin D is steroid saponins extracted from the Chinese herb Ophiopogonis Radix, and has a wide range of pharmacological effects such as anti-inflammation, anti-tumor, lipid lowering, myocardial protection, neuroprotection, gastrointestinal protection, and regulation of bone metabolism. In this article, researches on the pharmacological effects of ophiopogonin D conducted in recent years are reviewed and analyzed, to provide reference for its further development.

Key words

ophiopogonin D / pharmacological effects / research progress / anti-inflammatory effect / anti-tumor effect / lipid-lowering effect / myocardial protection effect / neuroprotective effect / gastrointestinal protection / regulation of bone metabolism

Cite this article

Download Citations
SUN Yan, ZHU Li-hong, CHEN Jun-yi, LI Rui-hua, ZHAO Fang-li, ZHOU Jing-yi. Research Progress in Pharmacological Effects of Ophiopogonin D. KANGGANRAN YAOXUE. 2024, 21(1): 1-5 https://doi.org/10.13493/j.issn.1672-7878.2024.01-001

References

[1] 薛亚,朱海青,张立超,等. 麦冬与山麦冬的本草考证[J]. 上海中医药大学学报,2022,36(3):89-93.
[2] Li XN, Wang YX, Sun P, et al.Determination of saponin content in Hang Maidong and Chuan Maidong via HPLC-ELSD analysis[J]. J Anal Methods Chem, 2016, 2016: 7214607.
[3] 迟宇昊,李暘,申远. 麦冬化学成分及药理作用研究进展[J]. 新乡医学院学报,2021,38(2):189-192.
[4] 彭婉,马骁,王建,等. 麦冬化学成分及药理作用研究进展[J]. 中草药,2018,49(2):477-488.
[5] 范明明,张嘉裕,张湘龙,等. 麦冬的化学成分和药理作用研究进展[J]. 中医药信息,2020,37(4):130-134.
[6] 姚泓,卢建秋,徐焕华,等. 建立UPLC-MS/MS 方法测定麦冬皂苷 D 和麦冬皂苷 D' 及临床风险评估[J]. 药物评价研究,2019,42(6):1135-1140.
[7] 彭文潘,徐泳,周运海,等. 基于网络药理学和实验验证探讨麦冬皂苷 D 治疗肺纤维化的作用机制[J]. 中国药理学通报,2023,39(8):1557-1565.
[8] 王宇华,缪娟,唐冉冉. 麦冬皂苷D 通过 PI3K/AKT 通路对卵巢癌细胞 8910 增殖、迁移、侵袭及凋亡的影响[J]. 肿瘤药学,2019,9(6):865-869.
[9] Zhu X, Wang K, Chen Y.Ophiopogonin D suppresses TGF-β1-mediated metastatic behavior of MDA-MB-231 breast carcinoma cells via regulating ITGB1/FAK/Src/AKT/β-catenin/MMP-9 signaling axis[J]. Toxicol In Vitro, 2020, 69: 104973.
[10] Zang QQ, Zhang L, Gao N, et al.Ophiopogonin D inhibits cell proliferation, causes cell cycle arrest at G2/M, and induces apoptosis in human breast carcinoma MCF-7 cells[J]. J Integr Med, 2016, 14(1): 51-59.
[11] 申鹏,汪正飞. 麦冬皂苷D 通过调控 miR-519d-3p/EIF4E 表达对肝癌细胞增殖、迁移、侵袭的实验研究[J]. 世界华人消化杂志,2019,27(24):1473-1482.
[12] Lee JH, Kim C, Lee SG, et al.Ophiopogonin D modulates multiple oncogenic signaling pathways, leading to suppression of proliferation and chemosensitization of human lung cancer cells[J]. Phytomedicine, 2018, 40: 165-175.
[13] Zhang YY, Han YW, Zhai KF, et al.Ophiopogonin-D suppresses MDA-MB-435 cell adhesion and invasion by inhibiting matrix metalloproteinase-9[J]. Mol Med Rep, 2015, 12(1): 1493-1498.
[14] Yan ZY, Liu GA, Liang M, et al.Ophiopogonin D inhibits cell proliferation and induces apoptosis of human laryngocarcinoma through downregulation of cyclin B1 and MMP-9 and upregulation of p38-MAPK signaling[J]. Oncol Lett, 2018: 17(2), 1877-1882.
[15] 康振朝,李晓,朱晓梅,等. 麦冬皂苷D 通过调控 miR-448/TLR4 轴抑制 LPS 诱导的胃癌细胞系 HGC-27 分泌细胞因子[J]. 免疫学杂志,2022,38(5):416-423.
[16] Ko HM, Jee W, Lee D, et al.Ophiopogonin D increase apoptosis by activating p53 via ribosomal protein L5 and L11 and inhibiting the expression of c-Myc via CNOT2[J]. Front Pharmacol, 2022, 13: 974468.
[17] 赵玲琳,张勇,薛慧,等. 麦冬皂苷D 对大鼠心肌细胞缺氧复氧损伤的保护作用及机制研究[J]. 中国循环杂志,2022,37(2):178-184.
[18] Zhang YY, Meng C, Zhang XM, et al.Ophiopogonin D attenuates doxorubicin-induced autophagic cell death by relieving mitochondrial damage in vitro and in vivo[J]. J Pharmacol Exp Ther, 2015, 352(1): 166-174.
[19] 曹斌,于梅. 麦冬皂苷D 对大鼠心肌细胞凋亡及 caspase 通路的影响[J]. 中国药师,2019,22(3):451-456.
[20] Wang Y, Huang XY, Ma ZC, et al.Ophiopogonin D alleviates cardiac hypertrophy in rat by upregulating CYP2J3 in vitro and suppressing inflammation in vivo[J]. Biochem Biophys Res Commun, 2018, 503(2): 1011-1019.
[21] 黄小燕,王宇光,王怡,等. 麦冬皂苷D 通过上调 CYP2J2/EETs 抗 Ang Ⅱ 诱导的内皮细胞凋亡[J]. 中国中药杂志,2018,43(2):377-384.
[22] 孟晨,袁彩华,张晨晨,等. 麦冬皂苷D 通过减轻内质网应激对阿霉素所致心肌损伤产生保护作用[J]. 药学学报,2014,49(8):1117-1123.
[23] 王佳,王宁宁,葛运炫,等. 麦冬皂苷D 干预内质网应激减轻麦冬皂苷 D' 所致心肌细胞损伤[J]. 中国中药杂志,2019,44(9):1876-1881.
[24] Kou JP, Tian YQ, Tang Y, et al.Antithrombotic activities of aqueous extract from Radix Ophiopogon japonicus and its two constituents[J]. Biol Pharm Bull, 2006, 29(6): 1267-1270.
[25] 刘彦娜,梁艳,王广基. 麦冬提取物中多种皂苷类成分的药代动力学[J]. 中国实验方剂学杂志,2014,20(9):137-142.
[26] Li WW, Ji LY, Tian J, et al.Ophiopogonin D alleviates diabetic myocardial injuries by regulating mitochondrial dynamics[J]. J Ethnopharmacol, 2021, 271: 113853.
[27] Huang XY, Wang YG, Wang Y, et al.Ophiopogonin D reduces myocardial ischemia-reperfusion injury via upregulating CYP2J3/EETs in rats[J]. Cell Physiol Biochem, 2018, 49(4): 1646-1658.
[28] Huang XY, Wang YG, Zhang ZY, et al.Ophiopogonin D and EETs ameliorate Ang II-induced inflammatory responses via activating PPARα in HUVECs[J]. Biochem Biophys Res Commun, 2017, 490(2): 123-133.
[29] 林毅. 麦冬皂苷D 调控 CYP2J 治疗心衰的分子机制研究[D]. 北京:军事科学院,2021.
[30] 汤响林,林毅,王宇光,等.麦冬皂苷D 对心肌细胞脂肪酸代谢酶的影响[J].中国中药杂志,2021,46(14):3672-3677.
[31] 张光晨,王一豪,阮盼盼,等. 麦冬皂苷D 对异丙肾上腺素诱导的心肌细胞损伤的保护作用及靶点初探[J]. 中国中药杂志,2022,47(10):2721-2728.
[32] 王远,王宇光,马增春,等. 麦冬皂苷D 通过降低自噬抑制血管紧张素 Ⅱ 诱导的心肌肥大[J]. 中国药理学通报,2016,32(10):1370-1376.
[33] 王远. 麦冬皂苷D 诱导 CYP2J 产生抗心肌肥大机制研究[D]. 南宁:广西医科大学,2017.
[34] Zhang YX, Qu SS, Zhang LH, et al.The role of ophiopogonin D in atherosclerosis: impact on lipid metabolism and gut microbiota[J]. Am J Chin Med, 2021, 49(6): 1449-1471.
[35] 辛颖,员丽培,王峰,等. 麦冬皂苷D 调控磷酸酶及张力蛋白同源物诱导激酶 1/帕金蛋白通路对脓毒症心肌损伤的保护作用[J]. 中国临床药理学杂志,2023,39(7):971-975.
[36] Wang JA, You WT, Wang NN, et al.Ophiopogonin D increases SERCA2a interaction with phospholamban by promoting CYP2J3 upregulation[J]. Oxid Med Cell Longev, 2020, 2020: 1-22.
[37] 蒋凤荣,张旭,洪艳丽. 麦冬皂苷D 对过氧化氢造模的 HUVEC 保护作用机制研究[J]. 现代生物医学进展,2008,8(9):1646-1648.
[38] You WT, Zhou T, Ma ZC, et al.Ophiopogonin D maintains Ca2+ homeostasis in rat cardiomyocytes in vitro by upregulating CYP2J3/EETs and suppressing ER stress[J]. Acta Pharmacol Sin, 2016, 37(3): 368-381.
[39] 任思嘉,徐焕华,李明,等. 麦冬皂苷D' 对大鼠心肌细胞 H9c2 的细胞毒性[J]. 中国药理学与毒理学杂志,2017,31(4):325-331.
[40] 林毅,杨春启,连闻雨,等. 麦冬皂苷D 通过铁死亡途径减轻麦冬皂苷 D' 所致心肌细胞损伤[J]. 药学学报,2021,56(8):2241-2247.
[41] 张婵娟,胡立坤,张贺,等. 2-Hydroxycircumdatin C 通过抑制 TLR4/NF-κB/MAPK 和 JAK2/STAT3 通路对脂多糖诱导 BV2 小胶质细胞发挥抗炎作用[J]. 中国药学(英文版),2022,31(4):239-249.
[42] 王亮,周子娟,詹红微,等. 麦冬皂苷D 对细菌脂多糖所致小肠上皮细胞损伤的保护作用[J]. 沈阳药科大学学报,2017,34(6):509-512,518.
[43] Wang L, Yang HB, Qiao L, et al.Ophiopogonin D inhibiting epithelial NF-κB signaling pathway protects against experimental colitis in mice[J]. Inflammation, 2022, 45(4): 1720-1731.
[44] 王莹,宋磊,孙立燕,等. 麦冬皂苷D 预处理对 PM2.5 介导肺泡 Ⅱ 型上皮细胞炎性损伤的抑制作用及其机制[J]. 山东医药,2018,58(32):25-28.
[45] 王莹. 麦冬皂苷D 通过激活 AMPK/NF-κB 信号通路缓解 PM2.5 诱导的肺泡上皮细胞炎症反应[D]. 长春:吉林大学,2019.
[46] 徐玲文,王华兵,揭凤英,等. 麦冬皂苷D 预处理对 LPS 介导的人肺上皮 Beas-2B 细胞炎性及氧化损伤的抑制作用[J]. 沈阳药科大学学报,2021,38(12):1302-1308.
[47] 徐玲文,王华兵,揭凤英,等. 麦冬皂苷D 对脂多糖诱导小鼠急性肺损伤的保护作用[J]. 中国呼吸与危重监护杂志,2021,20(7):503-508.
[48] Qiao YH, Jiao HY, Wang F, et al.Ophiopogonin D of Ophiopogon japonicus ameliorates renal function by suppressing oxidative stress and inflammatory response in streptozotocin-induced diabetic nephropathy rats[J]. Braz J Med Biol Res, 2020, 53(7): e9628.
[49] An EJ, Kim Y, Lee SH, et al.Ophiopogonin D ameliorates DNCB-induced atopic dermatitis-like lesions in BALB/c mice and TNF-α- inflamed HaCaT cell[J]. Biochem Biophys Res Commun, 2020, 522(1): 40-46.
[50] 陈奕澔,张雅心,江伟豪,等. 麦冬皂苷D 对高脂饲养 ApoE-/-小鼠血脂及肠道菌群的影响[J]. 中草药,2020,51(13):3501-3508.
[51] 唐小利. 麦冬皂苷D 治疗高脂饮食诱导的小鼠肥胖及其相关病症的效用研究[D].南京:南京师范大学,2016.
[52] Chen SY, Li XA, Liu L, et al.Ophiopogonin D alleviates high-fat diet-induced metabolic syndrome and changes the structure of gut microbiota in mice[J]. FASEB J, 2018, 32(3): 1139-1153.
[53] 张建武,孙浪,刘鑫,等. 麦冬皂苷D 诱导十二指肠平滑肌舒张作用及机制[J]. 中国老年学杂志,2019,39(12):3011-3013.
[54] Weick JP, Liu Y, Zhang SC.Human embryonic stem cell-derived neurons adopt and regulate the activity of an established neural network[J]. Proc Natl Acad Sci USA, 2011, 108(50): 20189-20194.
[55] Colangelo AM, Alberghina L, Papa M.Astrogliosis as a therapeutic target for neurodegenerative diseases[J]. Neurosci Lett, 2014, 565: 59-64.
[56] 杜荔娟,吴璨,谢黄泽,等. 运动调节星形胶质细胞改善阿尔茨海默病机制研究[J]. 生物化学与生物物理进展,2022,49(11):2156-2164.
[57] 李渊渊,刘峻崎,万凤,等. 麦冬皂苷D 对氧糖剥夺/复氧后新生鼠大脑皮层离体星形胶质细胞 HIF-1α-VEGF 通路的作用[J]. 中华中医药杂志,2018,33(4):1501-1506.
[58] 李倩,张烨君,李燃,等. 麦冬皂苷D 改善阿尔茨海默病模型大鼠认知功能的机制研究[J]. 局解手术学杂志,2022,31(12):1046-1051.
[59] 武晓群. 沙参麦冬汤和麦冬皂苷 D 延缓衰老的作用及机制研究[D]. 南京:南京中医药大学,2012.
[60] Ma XY, Wen XX, Yang XJ, et al.Ophiopogonin D improves osteointegration of titanium alloy implants under diabetic conditions by inhibition of ROS overproduction via Wnt/β-catenin signaling pathway[J]. Biochimie, 2018, 152: 31-42.
[61] 杨潜前,鲁琛. 麦冬皂苷D 调控 IGF-1/mTOR/PGE2 通路对脂多糖所致骨关节炎软骨细胞损伤的保护作用[J]. 现代实用医学,2020,32(4):429-432,418.
[62] Huang Q, Gao B, Wang L, et al.Ophiopogonin D: a new herbal agent against osteoporosis[J]. Bone, 2015, 74: 18-28.
[63] Yang M, Li CJ, Xiao Y, et al.Ophiopogonin D promotes bone regeneration by stimulating CD31hi EMCNhi vessel formation[J]. Cell Prolif, 2020, 53(3): e12784.
[64] Qian JC, Jiang FR, Wang B, et al.Ophiopogonin D prevents H2O2-induced injury in primary human umbilical vein endothelial cells[J]. J Ethnopharmacol, 2010, 128(2): 438-445.
[65] 王莹,唐兴华,孙立燕,等. 麦冬皂苷D 通过抑制 PI3K/Akt 信号通路减轻大气细颗粒物对肺泡上皮细胞的氧化损伤[J]. 中国老年学杂志,2019,39(2):397-399.
[66] Ji XF, Ding BD, Wu XY, et al.In vitro study on the effect of ophiopogonin D on the activity of cytochrome P450 enzymes[J]. Xenobiotica, 2021, 51(3): 262-267.
[67] Ishibashi H, Mochidome T, Okai J, et al.Activation of potassium conductance by ophiopogonin-D in acutely dissociated rat paratracheal neurones[J]. Br J Pharmacol, 2001, 132(2): 461-466.
[68] Tong YN, Yang LY, Yang Y, et al.An immunopotentiator, ophiopogonin D, encapsulated in a nanoemulsion as a robust adjuvant to improve vaccine efficacy[J]. Acta Biomater, 2018, 77: 255-267.
PDF(1436 KB)

694

Accesses

0

Citation

Detail

Sections
Recommended

/